Middle East and Africa Nasal Drug Delivery Market to Reach Market Value of USD 1.59 Billion by 2022

“Middle East and Africa Nasal Drug Delivery Market”
Middle East and Africa Nasal Drug Delivery Market Information, by Dosage Form (Drops, Sprays, Powder, Gels and Ointments), by System (Unit Dose, Multi-Dose And Metered Dose), by Delivery Technologies (Spray, Nebulizers And Other), by Therapeutic Applications (Rhinitis, Vaccinations, Congestion and Others) – Forecast till 2022

Market Forecast:

Market Research Future published a Half-Cooked Research Report on Middle East and Africa Nasal Drug Delivery Market. The Middle East and Africa Nasal Drug Delivery is estimated to reach around USD 1.59 Billion in 2022 growing at a CAGR of 8.1%; this market was worth USD 1 Billion in 2015.

Market Overview and Drivers:

The nasal route is increasingly being used for the delivery of drugs. The route offers many advantages over other routes such as its noninvasive nature, self-administration of the drug, reduction of pain and risk of infection associated with the injectable route. Self-administration also reduces the costs involved in the assisted administration of drugs. The route also avoids the first pass metabolism of drugs and is being considered for brain drug delivery due to its close association with the brain.

Other market driving factors of nasal drug delivery includes dosage reduction due to increased bioavailability and proportional reduction in side effects, growing efficacy of the route as drugs are absorbed easily from the nasal route and the development of advanced products such as metered dose pressurized containers which deliver a very precise dose. The growth of over the counter nasal drugs such as inhalers for common cold, and rhinitis is also driving the market since these advanced products also require nasal route of delivery. Off label use of symptomatic inhaler treatment is also an important market driver.

The market’s constraints includes irritation of the nasal route and the low dose of a drug that can be delivered through other route of administration, low awareness and low penetration of healthcare services in poor parts of Africa. The market is consolidated and reflects an oligopolistic outlook with a few dominant players. This allows a premium to be charged on most products.

Receive a Sample Report upon Request @ https://www.marketresearchfuture.com/sample_request/2696

Key Players:

Major participants of this market includes  Novartis AG, Pfizer, Inc., Sanofi-Aventis, Merck & Co., Inc., AptarGroup Inc., Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Becton Dickson & Company and others.

Middle East and Africa Nasal Drug Delivery Market:

The Middle East and Africa nasal drug delivery market has been evaluated to be a growing market and it is expected that the market will grow at a moderate CAGR in future. The Middle East and Africa nasal drug delivery market is expected to grow with CAGR of 8.1% during the forecast period. The growth will be primarily channeled by unmet medical needs, rising incomes of the population and the growing popularity of the route.

Access Report @ https://www.marketresearchfuture.com/reports/nasal-drug-delivery-market-2696

Regional Analysis:

Depending on geographic region, nasal drug delivery market is segmented into following countries which includes UAE, Egypt, Saudi Arabia, Kuwait, Qatar and Oman. UAE is the largest market followed by Egypt. The Saudi Arabia market is also rising due to rising healthcare expenditure and growing per capita income of the people. Among the African nations Algeria seems to hold a huge potential. However the future market will be led by some parts of Africa due to large unmet needs and growing awareness of nasal route.


Middle East and Africa nasal drug delivery market has been segmented on the basis of dosage form which comprises of drops, sprays, powder, gels and ointments. On the basis of system the market is segmented into unit dose, multi-dose and metered dose. On the basis of delivery technologies; market is segmented into spray, nebulizers and other. On the basis of therapeutic applications the market is again segmented into rhinitis, congestion, vaccinations and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: akash.anand@marketresearchfuture.com
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/nasal-drug-delivery-market-2696